Viewing Study NCT06304701



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06304701
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-02-12

Brief Title: Handwritten Text Production in Adults With Autism
Sponsor: Centre Hospitalier de Niort
Organization: Centre Hospitalier de Niort

Study Overview

Official Title: Analysis on Graphic Tablet of Motor and Cognitive Components of Written Production in Adults With and Without Autism Spectrum Disorder
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PEMTAA
Brief Summary: The main objective is to assess the psycholinguistic and graphomotor characteristics of written production in patients with ASD

The secondary objectives are

Identifying links between specific deficits of ASD and difficulties in written production
Identifying links between the severity of ASD and difficulties in written production

The primary evaluation criterion is the quantity of written production namely the number of words produced in 5 minutes on a text copying task BHK and in 15 minutes on each of the two written production tasks descriptive and persuasive

The secondary evaluation criteria are

Graphomotor indicators of written production writing speed pre-writing time pause time writing time handwriting size results obtained in BHK number of words produced letter height line parallelism telescoping ambiguous letters
Cognitive and psycholinguistic indicators of written production presence of titles presence of paragraphs number of sentences number of words per sentence lexical richness lexical field number of action verbs morphological complexity number of syntactic markers related to oneself number of syntactic markers related to others number of spelling errors evaluation of the overall quality of the produced text
Results obtained in tests writing habits questionnaire Autism Diagnostic Observation Scale second edition Wechsler Adult Intelligence Scale fourth edition - Similarities subtest Wechsler Adult Intelligence Scale fourth edition - Vocabulary subtest Rey Figure MASC
Detailed Description: Context

Autism Spectrum Disorder ASD is one of the neurodevelopmental disorders NDD characterized by persistent deficits in communication and social interaction and restricted and repetitive patterns of behavior interests and activities DSM-5 diagnostic criteria American Psychiatric Association 2013 These symptoms are present from early developmental stages and correspond to neurological conditions characterized by structural andor functional brain abnormalities

While diagnosis is typically made in childhood average age of 4 years Rogé 2019 many adults seek diagnostic evaluation for ASD from autism resource centers CRA This is partly due to the diversity of symptoms that can lead to a diagnostic odyssey spanning several years Rutherford et al 2016 Even though the dyad identified by DSM-5 allows for precise diagnosis many other clinical signs can be found in patients with ASD mood disorders sleep disorders impulsivityhyperactivity anxiety motor disorders language disorders etc which can complicate diagnosis and delay the implementation of early and appropriate intervention

In this context an interesting avenue is the study of writing characteristics in patients with ASD Indeed several studies show that patients with ASD present deficits in motor skills as well as in several psycholinguistic domains such as grammar morphology and phonology Habib et al 2019 Furthermore individuals with ASD may exhibit specific semantic and pragmatic impairments Bishop 1989 These findings may provide additional useful clues in a perspective of differential diagnosis and understanding of cognitive functioning

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None